France / Français
F.D.A. Approves Generic EpiPen That May Be Cheaper
3 monthes ago - By NY Times
Teva Pharmaceuticals will sell a generic copy of Mylan's EpiPen, which became the target of public outrage over its price.
Read more ...The FDA Finally Approved an EpiPen Generic. But a Shortage Looms Ahead of the School Year
3 monthes ago - By Fortune
The Food and Drug Administration on Thursday followed through on a long-standing mission to approve an EpiPen generic manufactured by Teva Pharmaceuticals. Teva stock jumped 7.3% in Thursday trading following the news that it will be the first company to market generics of Mylan's popular EpiPen and EpiPen Jr. auto-injectors, life-saving epinephrine devices that can treat deadly reactions to severe food allergies.
But, while the introduction of a generic EpiPen to the market could theoretically provide some financial relief to customers who have complained about the products' skyrocketing...
Read more ...US approves new generic competitor to EpiPen
3 monthes ago - By Philly
WASHINGTON - U.S. health officials have approved a new generic version of EpiPen, the emergency allergy medication.
Read more ...FDA approves Teva's generic EpiPen in blow to Mylan
3 monthes ago - By Business Insider
Teva Pharmaceutical's generic version of EpiPen just got approved by the FDA on Thursday.
Teva's stock is up 5.7% in Thursday afternoon trading.
The news is a blow to Mylan NV, and its stock dropped 1% following the announcement.
The U.S. Food and Drug Administration on Thursday approved Teva Pharmaceutical Industries Ltd's generic version of Mylan NV's EpiPen for the emergency treatment of allergic reactions.
"Today's approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our longstanding commitment to advance access to lower...
Read more ...
The headlines of Business Mag
HOLD FAMILY A multiplayer network game for families
Spend more time with your family and less with your phone with the Hold Family app made by us! :)
SØVN Modern sleep tracking study
The Søvn app is a modern sleep tracker made by us for Bryggen Research AS! #mobile #iOS #android #portfolio
SØVN Modern sleep tracking study
The Søvn app is a modern sleep tracker made by us for Bryggen Research AS! #mobile #iOS #android #portfolio
The stock market looks like it's past the point of no return - and not even...
Rising interest rates have been a significant catalyst of the corrections in equities this year. According to one Wall Street strategist, they've moved past a threshold that...
'It kind of feels like a scam': Employers are so desperate for workers...
In a tight job market , some employers are making job offers after a single phone interview , The Wall Street Journal reported. The tactic is one of many ways companies are...
A federal judge just sided with CNN and ordered the White House to restore...
A federal judge on Friday ordered the White House to restore the press pass of CNN's Jim Acosta. The Trump administration revoked Acosta's credentials after a combative...
Large Outflows Detected, iShares iBoxx $ Investment Grade Corp. Bond ETF
From ETF Channel : Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel , one standout is the iShares iBoxx $ Investment...
Industrial Production Increased 0.1% in October
From the Fed: Industrial Production and Capacity Utilization Industrial production edged up 0.1 percent in October, as a gain for manufacturing outweighed decreases elsewhere...
A hedge fund run by one of the world's most famous oil traders is the latest...
Andurand Commodities Fund lost 20.9% in October after predicting prices would rise. The fund, run by renowned oil trader Pierre Andurand, is one of the few oil specific funds...
The world has a new most expensive living artist after Christie's sale...
The sale of David Hockney's work smashes auction estimates with $90.3 million sale Hockney is now the most expensive living artist in the world, overtaking Jeff Koons. A...
CWS Market Review - November 16, 2018
“In a roaring bull market, knowledge is superfluous and experience is a handicap.” - Benjamin Graham Last week, I urged caution on the stock market's rebound. Sure enough, the...
Return on Content: A Review of How Spending Patterns on Content Marketing...
Content marketing is a growing sector, but are increased budgets leading to better outcomes? This blog summarizes some recent research from the Content Marketing...
The IMF just became the latest to warn about the $1.3 trillion 'leveraged...
The IMF has joined leading policy makers, major central banks, and global investors in raising the alarm over the buildup of corporate debt. It said default rates are rising...